ENGLEWOOD CLIFFS, NJ, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics ...

No new PTSD drug approvals in the U.S. in nearly 25 years; large potential addressable market for SPC-15 worldwide SARASOTA, FL, July 07, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (SILO) (“Silo” or ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/330598/bevacizumab_key) has announced the addition of the "Bevacizumab - Key ...

ENGLEWOOD CLIFFS, NJ, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Tofacitinib - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)" report to their offering. Need ...

Pillar Data Systems announced that its Pillar Axiom 600 storage system achieved outstanding performance and leading price-performance results for business-class storage based on its first SPC-1 ...